NADK and metabolic dysfunction-associated steatohepatitis: For example, EV-encapsulated miR-690 from KCs can maintain specific KC functions by downregulating NAD+ kinase (Nadk) mRNA levels and lead to reduced fibrosis in a mouse model of NASH (94).